Priority Date: 01.03.12 (EP 20120157680)

RHOGEF12 IS A THERAPEUTIC TARGET FOR THE TREATMENT OF HEART FAILURE

  • Application ID: EP13706573
  • Status: EXAMINATION IN PROGRESS

Attorney

Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Specialization

This patent has the IPC combination A01, A61, and C12 is specialized in the combination A01, A61, and C12. We found, that Isenbruck Bösl Hörschler LLP, Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Vereenigde Octrooibureaux NV (V.O.), Dennemeyer SA and 36 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 01.03.2012 - Priority Date (EP 20120157680)
  • 06.09.2013 - Publication A1 (WO2013128025)
  • 07.01.2015 - Publication A1 (EP2820130)

IPC Classification